A carregar...
Targeting survivin using a combination of miR-494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth
Castration-resistant prostate cancer (CRPC) remains an obstacle in the current treatment provided for prostate cancer (PCa). Survivin, an apoptosis inhibitor, has been found to be involved in the progression of PCa, and is a promising candidate target for CRPC therapy. Micro (mi) RNAs are involved i...
Na minha lista:
| Publicado no: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4732832/ https://ncbi.nlm.nih.gov/pubmed/26718651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4739 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|